These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 1127729

  • 1. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages.
    Harmel RP, zbar B.
    J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729
    [Abstract] [Full Text] [Related]

  • 2. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
    Schultz RM, Woods WA, Mohr SJ, Chirigos MA.
    Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825
    [Abstract] [Full Text] [Related]

  • 3. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
    Milas L, Hersh EM, Hunter N.
    Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
    [Abstract] [Full Text] [Related]

  • 4. Macrophage involvement in the protective effect of pyran copolymer against the Madison lung carcinoma (M109).
    Schultz RM, Papamatheakis JD, Luetzeler J, Ruiz P, Chirigos MA.
    Cancer Res; 1977 Feb; 37(2):358-64. PubMed ID: 832262
    [Abstract] [Full Text] [Related]

  • 5. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B, Manohar V, Sugimoto T, Ashley MP, Kato Y, Rappaport P.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M, Suit HD.
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract] [Full Text] [Related]

  • 7. Cellular and serum involvement in protection against Friend leukemia virus.
    Schuller GB, Morahan PS.
    Cancer Res; 1977 Nov; 37(11):4064-9. PubMed ID: 908040
    [Abstract] [Full Text] [Related]

  • 8. Effects of combined radiotherapy and immunotherapy with the use of pyran copolymer on murine fibrosarcoma.
    Collins AL, Song CW.
    J Natl Cancer Inst; 1978 Jun; 60(6):1477-81. PubMed ID: 650709
    [Abstract] [Full Text] [Related]

  • 9. Histopathology of the host response to Lewis lung carcinoma: modulation by pyran.
    Snodgrass MJ, Morahan PS, Kaplan AM.
    J Natl Cancer Inst; 1975 Aug; 55(2):455-62. PubMed ID: 1159827
    [Abstract] [Full Text] [Related]

  • 10. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
    Rao VS, Mitchell MS.
    J Biol Response Mod; 1983 Aug; 2(1):67-80. PubMed ID: 6606020
    [Abstract] [Full Text] [Related]

  • 11. Adoptive transfer of immunity against solid fibrosarcoma in mice with splenocytes and peritoneal exudate cells obtained after in vitro sensitization and in vivo immunization with cis-dichlorodiamine platinum(II) treated fibrosarcoma cells.
    Sodhi A, Tandon P, Sarna S.
    Arch Geschwulstforsch; 1985 Aug; 55(1):47-61. PubMed ID: 3872651
    [Abstract] [Full Text] [Related]

  • 12. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells.
    Zbar B, Canti G, Rapp HJ, Ashley MP, Sukumar S, Bast RC.
    Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533
    [No Abstract] [Full Text] [Related]

  • 13. Combination of active and passive immunization and chemotherapy to transplantation of methylcholanthrene-induced tumor in WKA rats.
    Gotoda E, Sendo F, Hosokawa M, Kodama T, Kobayashi H.
    Cancer Res; 1974 Aug; 34(8):1947-51. PubMed ID: 4842248
    [No Abstract] [Full Text] [Related]

  • 14. Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test.
    Shiku H, Bean MA, Old LJ, Oettgen HF.
    J Natl Cancer Inst; 1975 Feb; 54(2):415-25. PubMed ID: 1113324
    [Abstract] [Full Text] [Related]

  • 15. Immunomodulation and antitumor effects of MVE-2 in mice.
    Talmadge JE, Maluish AE, Collins M, Schneider M, Herberman RB, Oldham RK, Wiltrout RH.
    J Biol Response Mod; 1984 Dec; 3(6):634-52. PubMed ID: 6334720
    [Abstract] [Full Text] [Related]

  • 16. Cell and tissue distribution of 14C-labeled pyran copolymer.
    Papamatheakis JD, Schultz RM, Chirigos MA, Massicot JG.
    Cancer Treat Rep; 1978 Nov; 62(11):1845-51. PubMed ID: 728902
    [Abstract] [Full Text] [Related]

  • 17. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L, Hunter N, Mason K, Withers HR.
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract] [Full Text] [Related]

  • 18. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T, Himeno K, Mitani M, Mori K, Miake S, Nomoto K.
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [Abstract] [Full Text] [Related]

  • 19. Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers.
    Adams DO, Johnson WJ, Marino PA, Dean JH.
    Cancer Res; 1983 Aug; 43(8):3633-7. PubMed ID: 6861134
    [Abstract] [Full Text] [Related]

  • 20. Increased therapeutic efficacy and reduced toxicity of doxorubicin linked to pyran copolymer via the side chain of the drug.
    Zunino F, Pratesi G, Pezzoni G.
    Cancer Treat Rep; 1987 Apr; 71(4):367-73. PubMed ID: 3829013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.